Tag Archives: Compliance Processes

Smart Life Science and Unintelligent Quality System Management

Marci Lynn Crane asked: Will bioassays and mycoplasma-detection technology run the market distance? There are over 200,000 thousand laboratories in the United States alone1 and additional life science companies also include pharmaceutical, medical device, biotechnology and blood/tissue organizations. Most of these companies are usually respected within their production and sales communities and some companies even… Read More »